<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Symptom Advice .com &#187; research purposes</title>
	<atom:link href="http://symptomadvice.com/tag/research-purposes/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com</link>
	<description></description>
	<lastBuildDate>Tue, 29 May 2012 22:17:13 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>Clinical Trials Update: Jan. 18, 2011</title>
		<link>http://symptomadvice.com/clinical-trials-update-jan-18-2011/</link>
		<comments>http://symptomadvice.com/clinical-trials-update-jan-18-2011/#comments</comments>
		<pubDate>Sun, 23 Jan 2011 17:51:08 +0000</pubDate>
		<dc:creator>Symptom Advice</dc:creator>
				<category><![CDATA[psoriasis symptoms]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[medical condition]]></category>
		<category><![CDATA[psoriasis]]></category>
		<category><![CDATA[research purposes]]></category>

		<guid isPermaLink="false">http://symptomadvice.com/clinical-trials-update-jan-18-2011/</guid>
		<description><![CDATA[(HealthDay News) &#8212; &#104;&#101;&#114;&#101; are &#116;&#104;&#101; latest clinical trials, courtesy &#111;&#102; ClinicalConnection.com: Treatment Resistant Depression This study &#111;&#102; an investigational drug is for people &#119;&#104;&#111; are &#116;&#097;&#107;&#105;&#110;&#103; an antidepressant, but &#115;&#116;&#105;&#108;&#108; feel a lack &#111;&#102; energy or have unresolved symptoms &#111;&#102; depression. The research site is &#105;&#110; Upland, Calif. More information Please &#115;&#101;&#101; clinicalconnection.com/clinical_trials/condition/depression.aspx. Plaque [...]]]></description>
			<content:encoded><![CDATA[<p></p><p><img src="http://symptomadvice.com/wp-content/uploads/2011/01/1295805069-81.jpg%3Fw%3D468%26h%3D318" style="clear:both;clear:both;margin:0 15px 15px 0" />
<p>(HealthDay News) &#8212; &#104;&#101;&#114;&#101; are &#116;&#104;&#101; latest clinical trials, courtesy &#111;&#102; <b>ClinicalConnection.com</b>:</p>
<p><b> Treatment Resistant Depression </b></p>
<p> This study &#111;&#102; an investigational drug is for people &#119;&#104;&#111; are &#116;&#097;&#107;&#105;&#110;&#103; an antidepressant, but &#115;&#116;&#105;&#108;&#108; feel a lack &#111;&#102; energy or have unresolved symptoms &#111;&#102; depression.</p>
<p>The research site is &#105;&#110; Upland, Calif. </p>
<p><b>More information</b></p>
<p>Please &#115;&#101;&#101; clinicalconnection.com/clinical_trials/condition/depression.aspx.</p>
<p><b> Plaque Psoriasis </b></p>
<p> This study &#111;&#102; an investigational drug is for people aged 18 to 65 diagnosed &#119;&#105;&#116;&#104; psoriasis. &#116;&#104;&#101; trial is for research purposes, and is &#110;&#111;&#116; intended to treat a medical condition.</p>
<p>The research site is &#105;&#110; Miramar, Fla. </p>
<p><b>More information</b></p>
<p>Please &#115;&#101;&#101; clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.</p>
<p><b> Chronic Pain </b></p>
<p> To qualify for this study, you &#109;&#117;&#115;&#116; have chronic pain and &#098;&#101; &#116;&#097;&#107;&#105;&#110;&#103; prescription pain medication.</p>
<p>The research site is &#105;&#110; Dallas, Texas. </p>
<p><b>More information</b></p>
<p>Please &#115;&#101;&#101; clinicalconnection.com/clinical_trials/condition/chronic_pain.aspx.
<p>&#8212;&#8211;
<p>Copyright 2011 ClinicalConnection.com. All rights reserved.</p></p>
]]></content:encoded>
			<wfw:commentRss>http://symptomadvice.com/clinical-trials-update-jan-18-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
